Triptolide improves myocardial fibrosis in rats through inhibition of nuclear factor kappa B and NLR family pyrin domain containing 3 inflammasome pathway

Myocardial fibrosis (MF) is the result of persistent and repeated aggravation of myocardial ischemia and hypoxia, leading to the gradual development of heart failure of chronic ischemic heart disease. Triptolide (TPL) is identified to be involved in the treatment for MF. This study aims to explore t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Jianyao, Ma, Hailiang, Wang, Chaoquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552823/
https://www.ncbi.nlm.nih.gov/pubmed/34697264
http://dx.doi.org/10.4196/kjpp.2021.25.6.533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552823/
https://www.ncbi.nlm.nih.gov/pubmed/34697264
http://dx.doi.org/10.4196/kjpp.2021.25.6.533

Ejemplares similares